Suven Pharmaceuticals Ltd

SUVENPHAR

Company Profile

  • Business description

    Suven Pharmaceuticals Ltd is involved in developing and manufacturing intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs under Contract Research and Manufacturing Services (CRAMS) for global pharmaceutical, biotechnology, and chemical companies. The company operates majorly in the Manufacturing (CRAMS) segment, which includes bulk drugs and intermediates under contract services. Its geographical segments include India, the USA, Europe, and the Rest of the World. The majority of the company's revenue comes from the Europe segment.

  • Contact

    No. 202, A-Wing, Galaxy Towers
    Plot No.1, Hyderabad Knowledge City
    TSIIC, Raidurg
    HyderabadTG500081
    IND

    T: +91 4023549414

    https://www.suvenpharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2025

    Employees

    1,052

Stocks News & Analysis

stocks

The ASX healthcare player soaring to all-time highs

The steep market reaction comes after a recent announcement by the ACCC 
stocks

Ask the analyst: How long is WiseTech's growth runway?

Roy Van Keulen answers my question on how big a growth opportunity remains for the ASX's biggest technology company.
video

Why the ASX's most overlooked world champion is no dinosaur

Brambles is the undisputed king of pallet pooling. Esther Holloway joined me to talk about its moat, growth prospects and risk of disruption.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,416.6057.70-0.68%
CAC 407,541.3663.580.85%
DAX 4019,120.93105.520.55%
Dow JONES (US)42,352.75341.160.81%
FTSE 1008,280.631.89-0.02%
HKSE22,736.87623.362.82%
NASDAQ18,137.85219.371.22%
Nikkei 22538,635.6283.560.22%
NZX 50 Index12,619.9447.280.38%
S&P 5005,751.0751.130.90%
S&P/ASX 2008,150.0055.20-0.67%
SSE Composite Index3,336.50248.978.06%

Market Movers